A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis

N/AWithdrawnNCT01539395

MSDx, Inc.

Overview

This is a Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis.

Study Type

OBSERVATIONAL

Conditions

Multiple Sclerosis

Interventions

MSDx Complex-1 Biomarker TestOTHER

A biomarker test for the level of MSDx Complex-1

Eligibility

Sex: ALLMin age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age 45 years or older of either gender and of any racial/ethnic group. 2. Subjects must be in generally good health. 3. Subjects must be able and willing to comply with the requirements of the protocol. 4. Must be diagnosed with RRMS 5. Meets the criteria to enter Group 1 or Group 2 Exclusion Criteria: 1. Subject is currently in middle of an active episode of an autoimmune condition (e.g. rheumatoid arthritis, system lupus erythematosis) 2. Subject currently has a condition such as active influenza that would stimulate the immune system

Locations (1)

Northwest NeuroSpecialists, PLLC

Tucson, Arizona, United States

Outcomes

Primary Outcomes

Biomarker Differential

A difference in the levels of Complex-1 between subjects with controlled, stable MS vs. subjects in acute MS relapse

Time frame: Baseline

Secondary Outcomes

Biomarker reduction with steroid therapy

A decrease in the level of MSDx Complex-1 in response to steroid therapy for a relapse of MS.

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.